2021-11-16-世界卫生组织-Cervical_cancer_Mexico_2021_country_profile_1页_65kb

Mexico Summary: Cervical Cancer Profile

Morbidity and Mortality

• Crude cervical cancer incidence: 15.3 per 100,000 women (2020).
• Age-standardized incidence rate: 12.6 per 100,000 women (2020).
• Cumulative risk by age 0-74: 1.3%.
• Cervical cancer deaths: 4,800 (2019).
• Mortality-to-incidence ratio: 0.46 (2020).
• Population-based cancer registry exists (2021: yes).

Primary Prevention (HPV Vaccination)

• HPV vaccination programme coverage among girls: High, with 99% coverage by age 15 for final dose.
• Year of introduction: 2012.
• Primary target cohort: Girls aged 9-14 years.
• Scale: Universal coverage.
• Related risk factors: Low tobacco use prevalence (6%) among women aged 15+, other factors not specified fully.

Secondary Prevention (Screening)

• National screening programme for cervical cancer exists (2021: yes), with primary test cytology.
• Target age range: 25-64 years.
• Ever screened among women aged 30-49 years: 77% over 5 years.
• Screening coverage: 88% of women have been screened in the last 5 years.

Treatment and Supportive Care

• National guidelines exist (2021: yes).
• Medical resources: Adequate radiotherapy and chemotherapy services, with staff numbers reported.
• Cancer facilities: Tertiary cancer centres available.

WHO Cervical Cancer Elimination Strategy (2030)

• Aligns with WHO targets, including reduction in incidence and mortality.